The Role of Interoceptive Sensitivity in Central Sensitization Symptom Severity in Fibromyalgia
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07878286, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
- Trial code
- NCT07878286
- Record updated
- 16 October 2026
- Original description
In fibromyalgia, the increased central sensitization symptom burden can lead to a disruption in the individual's interoception and difficulties in managing symptoms. Additionally, impaired internal perception can also affect conditions such as pain severity, fatigue, sleep quality, and accompanying depression and anxiety in fibromyalgia patients. With this study, the relationship between central sensitization and interoceptive sensitivity in fibromyalgia will be examined, and the relationship of interoceptive sensitivity with issues such as sleep quality, pain severity, fatigue, anxiety, and depression in fibromyalgia patients will also be investigated.Read full original descriptionShow less
Association Between Interoceptive Sensitivity and Central Sensitization Symptom Burden in Women With Fibromyalgia: A Cross-Sectional Study
In fibromyalgia, the increased central sensitization symptom burden can lead to a disruption in the individual's interoception and difficulties in managing symptoms. Additionally, impaired internal perception can also affect conditions such as pain severity, fatigue, sleep quality, and accompanying depression and anxiety in fibromyalgia patients. With this study, the relationship between central sensitization and interoceptive sensitivity in fibromyalgia will be examined, and the relationship of interoceptive sensitivity with issues such as sleep quality, pain severity, fatigue, anxiety, and depression in fibromyalgia patients will also be investigated.
Inclusion: Women patients aged 18-65; Diagnosed with fibromyalgia according to the 2016 ACR criteria; Experiencing widespread pain for at least 3 months; Having the cognitive ability to complete the scales; Having read and signed the informed consent form (ICF).
Exclusion: Active inflammatory rheumatic disease; Neurological disease; Malignancy; Severe psychiatric disorder; Serious systemic disease such as heart or kidney failure; Being under 18 or over 65 years old; Pregnancy.